title: Characterization of differential antibody production against hepatitis C virus in different HCV infection status.
abstract: The Centers for Disease Control and Prevention (CDC) issued an update on hepatitis C virus (HCV) testing approach, in which it omitted the use of recombinant immunoblot assay (RIBA) in the diagnostic algorithm and recommended that future studies are needed to evaluate the performance of HCV testing without RIBA. As Egypt has the highest prevalence of HCV worldwide, we aimed to evaluate the value of RIBA in HCV testing in a high prevalence population. Our objective was to clarify whether enzyme linked immunosorbent assay (ELISA) anti-HCV signal-to-cutoff (S/CO) ratios were able to discriminate true positive from false positive anti-HCV antibody status and to evaluate the role of RIBA in solving this problem which may lead to a redefined strategy for diagnosis of HCV infection. Our second objective was to elucidate the effects of different HCV peptides of both structural and non-structural proteins on the humoral immune response to HCV infection.
  
  
  
  The current study drew results from 167 individuals divided into three groups: Group I: included 77 HCV antibody positive (ELISA) high risk health care workers (HCW), Group II: included 56 presumably uninfected individuals who showed normal liver enzymes, negative HCV RNA and were asymptomatic. Their ELISA HCV antibody S/C ratio ranged from 0.9 to <5. Group III: included 34 patients enrolled from outpatient clinics of Ain Shams Hospital with persistent viral replication, elevated liver enzymes, and chronic HCV related liver disease. All study participants were assessed for the presence of anti-HCV antibodies by 3(rd) generation ELISA which was confirmed by RIBA.
  
  
  
  Interpreting the results of both ELISA and RIBA together, false positive results were highly significantly increased in HCW when compared with the other two groups. Indeterminate and false negative results were only found in the presumably uninfected group. For differentiated antibody responses by RIBA, chronic HCV cases had the highest frequency of positive antibody response to core peptides while the presumably uninfected group had the lowest. Antibody response to E2 was found less frequently in chronic cases than Core 1, Core 2 and NS3. The specific antibody response to the different HCV peptides showed the same distribution of frequencies in both chronic HCV cases and the presumably uninfected individuals with the chronic cases having the highest frequencies. This distribution was different from the HCW. The most evident difference was the reaction towards NS3 which was the highest antibody producing peptide in chronic HCV and presumably uninfected individuals whereas in HCW Core1 was the highest.
  
  
  
  The HCV antibody immunoblot assay (RIBA) is still necessary for the detection of false positive cases which can occur quite frequently in countries of high prevalence as Egypt. Indeterminate RIBA results indicate a waning antibody response in elderly individuals who recovered from previous or distant HCV infection.
authors.affiliation: Clinical and Chemical Pathology Department, Faculty of Medicine, Ain Shams University, Children village, POB 9505, Nasr city, Cairo, Egypt.
authors.forename: Mona
authors.initials: M
authors.lastname: Rafik
authors.affiliation: Clinical and Chemical Pathology Department, Faculty of Medicine, Ain Shams University, Children village, POB 9505, Nasr city, Cairo, Egypt.
authors.forename: Salwa
authors.initials: S
authors.lastname: Bakr
authors.affiliation: Clinical and Chemical Pathology Department, Faculty of Medicine, Ain Shams University, Children village, POB 9505, Nasr city, Cairo, Egypt.
authors.forename: Dina
authors.initials: D
authors.lastname: Soliman
authors.affiliation: Clinical and Chemical Pathology Department, Faculty of Medicine, Ain Shams University, Children village, POB 9505, Nasr city, Cairo, Egypt.
authors.forename: Nesrine
authors.initials: N
authors.lastname: Mohammed
authors.affiliation: Clinical and Chemical Pathology Department, Faculty of Medicine, Ain Shams University, Children village, POB 9505, Nasr city, Cairo, Egypt. dinaragab@med.asu.edu.eg.
authors.forename: Dina
authors.identifier: 0000-0003-4738-9853
authors.initials: D
authors.lastname: Ragab
authors.affiliation: Clinical and Chemical Pathology Department, Faculty of Medicine, Ain Shams University, Children village, POB 9505, Nasr city, Cairo, Egypt.
authors.forename: Walid Abd
authors.initials: WA
authors.lastname: ElHady
authors.affiliation: Clinical and Chemical Pathology Department, Faculty of Medicine, Ain Shams University, Children village, POB 9505, Nasr city, Cairo, Egypt.
authors.forename: Nancy
authors.initials: N
authors.lastname: Samir
mesh_terms: D000328:Adult; D000368:Aged; D004797:Enzyme-Linked Immunosorbent Assay; D016174:Hepacivirus / Q000235:genetics / Q000276:immunology*; D006526:Hepatitis C / Q000097:blood / Q000276:immunology / Q000821:virology*; D018937:Hepatitis C Antibodies / Q000097:blood* / Q000276:immunology; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D018937:Hepatitis C Antibodies
keywords: Antibody response; HCV Ag; RIBA